Jeffrey M. Cerio
Senior VP, General Counsel & Corporate SecretaryDr. Jeffrey M. Cerio, Pharm.D., J.D., also known as Jeff, is Senior VP, Corporate Secretary & General Counsel of Korro Bio Inc. since August 30, 2024. He Joined Korro Bio Inc. since August 30, 2024. He served as General Counsel and Corporate Secretary of Atomwise, Inc. since January 2022 until August 2024. He served as Senior Vice President, General Counsel and Secretary of Triplet Therapeutics, Inc. from November 2019 to August 2021. Dr. Cerio joined Triplet Therapeutics, Inc. in 2019 and has experience leading and advising life sciences companies on various legal matters relating to corporate governance, business development, financing, securities law, compliance and intellectual property. Before joining Triplet, he served as Senior Corporate Counsel, Securities at Moderna, Inc. from June 2018 to November 2019. Previously Dr. Cerio served as a securities and business development counsel at Alkermes plc in roles of increasing responsibility and prior to that was a corporate attorney in the life sciences practice at the law firm Ropes & Gray LLP. Dr. Cerio received his Pharm.D. from Northeastern University and his J.D. from the University of Connecticut School of Law.
Positions
- Company NameKorro Bio, Inc.Stock CodeKRROPositionSenior VP, General Counsel & Corporate SecretaryColleagues
- RARam AiyarCEO, President, Interim CFO, Principal Financial Officer & Director
- NBNessan BerminghamCo-Founder & Independent Chairman of the Board
- JFJean-Francois FormelaCo-Founder & Director
- LVLoic VincentChief Scientific Officer
- AFAndrew FraleyCo-Founder & Advisor
- ABAli BehbahaniIndependent Director
- TRTimothy R. PearsonIndependent Director
